Shares of Interactive Brokers Group, Inc. IBKR have gained 56.2% so far this year, outperforming the S&P 500 Index’s 12.2% rise and the industry’s 24.1% growth. Since the beginning of this year, IBKR ...
Electronic brokerage firm Interactive Brokers (NASDAQ:IBKR) will be reporting earnings this Thursday after market close. Here’s what investors should know. Interactive Brokers beat analysts’ revenue ...
Interactive Brokers Group IBKR-1.63%decrease; red down pointing triangle posted higher profit in the third quarter as traders continued to pour into stocks and options. The online brokerage platform ...
Amid the evolving trading market, Interactive Brokers is expected to continue to gain from higher client engagement. Its initiatives to expand the product suite and the reach of its services will ...
Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, has announced the release of Version 1.2 of IBKR Desktop, a next-generation trading platform that balances simplicity with ...
Interactive Brokers Launches Enhanced Versions of IBKR Desktop with One-Click, Instant Order Placement. With IBKR Desktop, clients can trade products from over 160 global exchanges, including stocks, ...
Chris is a writer and editor with over 10 years of experience covering games and has a bachelor's degree in History from the University of Central Lancashire. He's mainly focused on guides, but has ...
Some investors looking to survey the damage to their stock portfolios this morning encountered frustrating technical glitches at brokerages including Fidelity Investments and Robinhood Markets.
U.S. stock futures have eased off their session highs, but still pointed to a higher open for stocks once the opening bell rings on Wall Street. The impetus for these gains was the September CPI ...
On The Outer Worlds 2 map, you'll see the multiple planets that are part of Arcadia that you end up visiting, during your journey as an Earth Directorate agent. This vast and rich colony has been the ...
Danish vaccine developer Evaxion has released long-term data for its lead personalized cancer vaccine, with the shot scoring a 75% objective response rate (ORR) in patients with advanced melanoma ...